Oculis (NASDAQ:OCS) Earns Buy Rating from Chardan Capital

Chardan Capital reissued their buy rating on shares of Oculis (NASDAQ:OCS – Free Report) in a report issued on Tuesday, Benzinga reports. Chardan Capital currently has a $30.00 price target on the stock. Several other analysts have also recently weighed in on OCS. Robert W. Baird boosted their price target on Oculis from $35.00 to […]

Leave a Reply

Your email address will not be published.

Previous post 50 years of the Porsche 911 Turbo
Next post RBC Bearings (NASDAQ:ROLL) Earns Hold Rating from Analysts at StockNews.com